Earlier this month, Deputy Attorney General Lisa O. Monaco spoke on cybersecurity developments at the International Conference on Cyber Security (“ICCS”); the same day, the U.S. Department of Justice (“DOJ”) released its...more
The Department of Justice (“DOJ”) recently announced a new Civil Cyber-Fraud Initiative (the “Initiative”) that will use the False Claim Act (“FCA”) to pursue contractors and grant recipients that knowingly...more
10/20/2021
/ Cybersecurity ,
Cybersecurity Maturity Model Certification (CMMC) ,
Data Protection ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Federal Contractors ,
Information Technology ,
Popular ,
Privacy Concerns ,
Qui Tam ,
Whistleblowers
In late 2019, Gustav Eyler, the Director of the U.S. Department of Justice’s (“DOJ”) Consumer Protection Branch (“CPB”), cited fraudulent data in clinical research trials for new drugs and medical devices as a topic of “major...more
3/23/2021
/ Clinical Laboratory Testing ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Corruption ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Enforcement ,
False Statements ,
Food and Drug Administration (FDA) ,
Fraud ,
Medical Devices ,
Medical Research ,
Pharmaceutical Industry ,
Popular ,
Willful Misconduct ,
Wire Fraud